540 related articles for article (PubMed ID: 9857536)
1. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
2. In vivo platelet release in myeloproliferative disorders.
Ireland H; Lane DA; Wolff S; Foadi M
Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
[TBL] [Abstract][Full Text] [Related]
3. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
4. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
5. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
6. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation in myeloproliferative disorders.
Cortelazzo S; Viero P; Barbui T
Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
[TBL] [Abstract][Full Text] [Related]
8. Platelet function studies in myeloproliferative disorders.
Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
Petrides PE; Siegel F
Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
[TBL] [Abstract][Full Text] [Related]
10. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
Nishimura J; Okamoto S; Ibayashi H
Thromb Haemost; 1979 Jun; 41(4):787-95. PubMed ID: 483250
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
14. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
15. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
[TBL] [Abstract][Full Text] [Related]
16. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
17. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals.
Seyfert UT; Haubelt H; Vogt A; Hellstern P
Platelets; 2007 May; 18(3):199-206. PubMed ID: 17497431
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
[TBL] [Abstract][Full Text] [Related]
19. Assessment of platelet adhesiveness and aggregation in mild acute pancreatitis using the PFA-100 system.
Mimidis K; Papadopoulos V; Kartasis Z; Baka M; Tsatlidis V; Bourikas G; Kartalis G
JOP; 2004 May; 5(3):132-7. PubMed ID: 15138334
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
